CVE-2026-105174Gerapy Project Management views.py project_create path traversal
Updated under an hour ago ()
Does this affect you?
It affects n/a Gerapy. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
A vulnerability has been found in Gerapy up to 0.9.13. This vulnerability affects the function project_create of the file gerapy/server/core/views.py of the component Project Management. The manipulation of the argument project_name leads to path traversal. Remote exploitation of the attack is possible. The exploit has been disclosed to the public and may be used. The identifier of the patch is 6e481078cfba6388a67ca2d9792288405019ba3e. Applying a patch is the recommended action to fix this issue.
- CVSS
- 5.4 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:L/E:P/RL:O/RC:C
- Weakness (CWE)
- CWE-22
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- VulDB
- NVD analysis
- Deferred
- Record last updated
- Oct 6, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
n/a Gerapy gerapy:gerapy | 0.9.0; 0.9.1; 0.9.2; 0.9.3; 0.9.4; 0.9.5; 0.9.6; 0.9.7; and 6 more ranges | CNA record |
References
- https://vuldb.com/vuln/413406vdb-entry, technical-description
- https://vuldb.com/vuln/413406/ctisignature, permissions-required
- https://vuldb.com/cve/CVE-2026-105174third-party-advisory
- https://vuldb.com/submit/970586third-party-advisory
- https://github.com/Gerapy/Gerapy/issues/317exploit, issue-tracking
- https://github.com/Gerapy/Gerapy/pull/319issue-tracking, patch
- https://github.com/Gerapy/Gerapy/commit/6e481078cfba6388a67ca2d9792288405019ba3epatch
- https://github.com/Gerapy/Gerapy/product
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.